Driving the biomanufacturing revolution with process intensification
An increase in therapies targeting smaller niche segments of the market rather than blockbuster drugs for large patient populations is creating new pressures on biomanufacturers to meet patient needs. As a result, there is a growing focus on implementing process intensification approaches as a way to produce high-quality drugs in a more efficient and cost-effective way. Whether it is referred to as bioprocess intensification, intensified biomanufacturing, or intensified processing, the goal of process intensification is the same — to increase productivity per some form of measurement, such as in time, volume, or dollars. Through an integration of technologies, operation simplification, and insights via analytics, process intensification offers a wide range of opportunities to enhance drug development and manufacturing. Leveraging this extended connected platform with increased data sharing could revolutionize biomanufacturing, providing a route to risk reduction and economic global manufacturing in an increasingly fragmented market. Yet, in today’s industry, how does one do more with less?
As a supplier dedicated to preparing today’s industry for the future of bioprocessing, Cytiva has compiled this ebook about solutions and strategies you can consider during your own journey toward a faster and more flexible, cost-effective approach to drug development and manufacturing. It is only through the support of your goals that we can become a true partner in realizing the business needs of our customers and driving the innovation necessary to revolutionize patient care.